7-82066526-TAAAAAAA-TAAAAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000722.4(CACNA2D1):​c.659-4_659-3delTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0299 in 1,348,660 control chromosomes in the GnomAD database, including 56 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 55 hom., cov: 27)
Exomes 𝑓: 0.031 ( 1 hom. )

Consequence

CACNA2D1
NM_000722.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.23

Publications

3 publications found
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
  • short QT syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • developmental and epileptic encephalopathy 110
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Brugada syndrome
    Inheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, Ambry Genetics
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-82066526-TAA-T is Benign according to our data. Variant chr7-82066526-TAA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 518490.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0626 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000722.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
NM_000722.4
MANE Select
c.659-4_659-3delTT
splice_region intron
N/ANP_000713.2P54289-2
CACNA2D1
NM_001366867.1
c.659-4_659-3delTT
splice_region intron
N/ANP_001353796.1P54289-1
CACNA2D1
NM_001302890.2
c.659-4_659-3delTT
splice_region intron
N/ANP_001289819.1E7ERK3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
ENST00000356860.8
TSL:1 MANE Select
c.659-4_659-3delTT
splice_region intron
N/AENSP00000349320.3P54289-2
CACNA2D1
ENST00000423588.1
TSL:1
c.659-4_659-3delTT
splice_region intron
N/AENSP00000405395.1E7ERK3
CACNA2D1
ENST00000443883.2
TSL:5
c.659-4_659-3delTT
splice_region intron
N/AENSP00000409374.2H0Y715

Frequencies

GnomAD3 genomes
AF:
0.0210
AC:
2346
AN:
111648
Hom.:
55
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0649
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00650
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000257
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00488
Gnomad MID
AF:
0.00909
Gnomad NFE
AF:
0.000602
Gnomad OTH
AF:
0.0184
GnomAD2 exomes
AF:
0.0775
AC:
7016
AN:
90532
AF XY:
0.0777
show subpopulations
Gnomad AFR exome
AF:
0.135
Gnomad AMR exome
AF:
0.0938
Gnomad ASJ exome
AF:
0.0760
Gnomad EAS exome
AF:
0.0757
Gnomad FIN exome
AF:
0.0531
Gnomad NFE exome
AF:
0.0667
Gnomad OTH exome
AF:
0.0756
GnomAD4 exome
AF:
0.0306
AC:
37912
AN:
1237034
Hom.:
1
AF XY:
0.0318
AC XY:
19387
AN XY:
610022
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0892
AC:
2413
AN:
27058
American (AMR)
AF:
0.0745
AC:
2050
AN:
27528
Ashkenazi Jewish (ASJ)
AF:
0.0455
AC:
984
AN:
21636
East Asian (EAS)
AF:
0.0431
AC:
1389
AN:
32244
South Asian (SAS)
AF:
0.0563
AC:
3621
AN:
64260
European-Finnish (FIN)
AF:
0.0507
AC:
1835
AN:
36186
Middle Eastern (MID)
AF:
0.0371
AC:
144
AN:
3884
European-Non Finnish (NFE)
AF:
0.0242
AC:
23596
AN:
973292
Other (OTH)
AF:
0.0369
AC:
1880
AN:
50946
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.266
Heterozygous variant carriers
0
4312
8625
12937
17250
21562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0210
AC:
2347
AN:
111626
Hom.:
55
Cov.:
27
AF XY:
0.0212
AC XY:
1124
AN XY:
52912
show subpopulations
African (AFR)
AF:
0.0649
AC:
2193
AN:
33812
American (AMR)
AF:
0.00650
AC:
68
AN:
10468
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2614
East Asian (EAS)
AF:
0.000258
AC:
1
AN:
3870
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3484
European-Finnish (FIN)
AF:
0.00488
AC:
25
AN:
5122
Middle Eastern (MID)
AF:
0.00990
AC:
2
AN:
202
European-Non Finnish (NFE)
AF:
0.000602
AC:
30
AN:
49808
Other (OTH)
AF:
0.0183
AC:
28
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
96
192
288
384
480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0385
Hom.:
11

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
CACNA2D1-related disorder (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370103843; hg19: chr7-81695842; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.